跳至主要内容
临床试验/TCTR20220921003
TCTR20220921003尚未招募3 期

Preoperative plasma transfusion versus no plasma transfusion strategies in cirrhosis patients with prolong INR level undergoing prophylactic esophageal band ligation: An open-label, randomized non-inferiority multi-center trial.

Chulalongkorn University0 个研究点目标入组 1,100 人开始时间: 2022年9月21日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
1,100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 1. Cirrhosis patients diagnosed by clinical signs and/or liver function tests and/or imaging and/or liver biopsy, 2. Baseline international normalized ratio (INR) 1.5 to 2.5, 3. Have a history of esophageal varice, 4. Undergoing a prophylaxis esophageal band ligation.

排除标准

  • 1. Hereditary or acquired coagulopathy other than liver diseases, 2. Evidence of hemodynamic instability, 3. History of active infection within 2 weeks, 4. Renal insufficiency (Creatinine 2.0 mg/dL or over), 5. Taking antiplatelet and/or anticoagulant

研究者

相似试验

Restrictive plasma transfusion in cirrhosis, a... | 临床试验